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Abstract— Peptide and protein sequences are most commonly
represented as a strings: a series of letters selected from the
twenty character alphabet of abbreviations for the naturally
occurring amino acids. Here, we experiment with representations
of small peptide sequences that incorporate more physiochemical
information. Specifically, we develop three different physiochem-
ical representations for a set of roughly 700 HIV–I protease
substrates. These different representations are used as input to
an array of six different machine learning models which predict
whether or not a given peptide is likely to be an acceptable
substrate for the protease. Our results show that, in general,
higher–dimensional physiochemical representations tend to have
better performance than representations incorporating fewer
dimensions selected on the basis of high information content. We
contend that such representations are more biologically relevant
than simple string–based representations and are likely to more
accurately capture peptide characteristics that are functionally
important.
Index Terms— Machine learning, peptide, modeling, physio-
chemical properties
I. INTRODUCTION
IN this manuscript we discuss the modeling of small peptidesequences. Most commonly, peptides and protein sequences
are represented as a string of letters drawn from the alphabet
of characters representing the twenty natural amino acids.
Here, we use a more meaningful representation of amino acids
and test the ability of various machine learning techniques to
predict peptide function. Specifically, we develop a set of three
amino acid representation schemes and test these schemes
combinatorially with a set of six machine learning techniques.
A. Amino acid representations
The most common representation of small peptides are as
strings of letters representing the twenty amino acids, e.g.
KWRAG, which is the five residue sequence lysine, tryptophan,
arginine, alanine, and glycine. Notably, both amino acid names
and their corresponding abbreviations are human constructs
that carry no information about the underlying physiochemical
characteristics of each amino acid. That is, the string KWRAG
carries little information in and of itself, without some infor-
mation about what a K is and how it is different from the other
amino acids. In place of such physical descriptions, previous
efforts have described the similarity of amino acids based
on the tendency for one amino acid to substitute for another
in homologous, similarly–functioning proteins across different
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species [1], [2]. That is, substitutions that are observed in
nature can be construed in some sense as indicating similarity
between certain amino acids. While such efforts have been
extremely useful for tasks such as aligning more distant protein
homologs, they typically do not capture enough information to
be practically useful in de novo design or prediction of protein
activity.
Here we experiment with feature vector representations
of small peptides using sets of amino acid physiochemical
characteristics derived from the AAindex database [3]–[5].
The AAindex database lists 453 physiochemical parameters
for each of the twenty amino acids. These parameters range
from those that are very tangible and intuitive — for example,
residue volume, which is AAindex parameter BIGC670101 [6]
— to the abstract — for example, the normalized frequency of
participation in an N-terminal beta–sheet, which is AAindex
parameter CHOP780208 [7]. The parameters were culled from
the scientific literature by the AAindex authors and might
be considered the universe of what we, as the scientific
community, know about each amino acid.
Thus, a very logical way of representing an amino acid
is as a feature vector of these 453 attributes. In this sense
each type of amino acid has a different feature vector of the
same dimensionality. This might be considered the “maximally
informative” representation of the amino acids since it incor-
porates an expansive set of features culled from the literature.
Extending this, we could write an amino acid sequence as
the concatenation of these vectors. That is, a three residue
peptide could be represented as a 3 ∗ 453 = 1359 feature
vector. Intuitively, this representation retains more information
than the string representation. Further, we would imagine that
the physiochemical representation would be more useful for
modeling the function of a peptide sequence, such as its
propensity to fold in a certain manner or to react with a certain
enzyme.
The representation of amino acids has received some previ-
ous attention in the literature. For example, Atchley et. al. [8]
use the physiochemical parameters from the AAindex to create
a low–dimensional projection of the characteristics of each
of the twenty natural amino acids. Further, they used this
low–dimensional progression to derive metrics of similarity
between the amino acids, similar to popular amino acid scoring
matrices such as Blosum [1] and PAM [2].
B. HIV–I Protease
In this work we will use the HIV–I protease as a model sys-
tem for demonstrating the merits of different physiochemical
amino acid representations. Specifically, we show the success
of different representations and different machine learning
methods at modeling substrate specificity of the protease.
The HIV–1 protease is a proteolytic enzyme encoded by
the HIV genome [9]. The protease plays a critical role in
viral replication and the development of viral structure [10].
The protease recognizes specific eight–residue sequences in its
substrates (see Figures 1 and 2). The protease’s natural targets
are subsequences of other HIV genes which must be cleaved
for the virus to successfully replicate. Accordingly, small
molecule inhibitors of the protease are a common therapy for
HIV/AIDS [11].
Fig. 1. Structure of the HIV–I protease, derived from the Protein Data
Bank (PDB) [12] entry 7HVP [13]. Over one hundred other structures of the
protease have been solved since the first in 1989 and are available from the
PDB’s website. The protein is a dimer of two 99 amino acid chains. The
regions of the protein at the top of the figure, the “flaps,” open up and accept
a substrate protein, closing behind it. Two aspartate residues in the active site,
aided by the presence of water, act to cleave the substrate.
Fig. 2. Schematic of the HIV–I protease active site. The active site comprises
eight binding pockets (P1–P4 and P1’–P4’) into which eight residues from
the target protein fall. The target protein is cleaved between the S1 and S1’
residues. One half of the catalytic unit is made up by chain A of the protease
and the other by chain B (see Figure 1).
In addition to the handful of sites that the protease cleaves
to facilitate viral development, it can cleave a number of other
“non–natural” substrates [14]. These substrates have been the
focus of intense experimental study [15]–[18]. In a recent
manuscript, You et. al. collected a comprehensive set of 700+
eight–residue substrates that have been tested for cleavability
by the HIV–I protease [19]. In addition, You et. al. developed a
series of models for the protease’s substrate selectivity that, in
general, outperform previous computational models [20]–[23],
which relied on a much smaller dataset [24].
II. METHODS
A. Amino acid representations and input data set
A set of 746 eight–residue peptides were generously pro-
vided by You et. al. [19], each with a class: cleavable by the
HIV–I protease or not cleavable. In addition, the complete set
of 453 physiochemical parameters for each of the 20 naturally
occurring amino acids was downloaded from the AAindex
database (release 7.0, July 2005).
From these 453 parameters, we removed redundant parame-
ters for which the magnitude of the correlation coefficient with
another parameter was greater than 0.80. The remaining 155
independent parameters were kept. Using these parameters,
we made three different projections of the 746 experimentally
tested protease substrates as detailed below.
1) Full physiochemical projection: In this projection each
eight–residue peptide was represented as a 1241–dimensional
feature vector: 8 residues with 155 physiochemical features
per residue plus the class — cleaved or not cleaved. Of our
three representations, this one retains the most information
about the peptides.
2) Feature–selected physiochemical projection: Using the
“FULL” projection (above) we performed a feature selection
routine to select only those features that are most correlated
to the class. (Throughout this manuscript, all modeling and
feature selection were performed using the Waikato Environ-
ment for Knowledge Analysis, or WEKA [25]). Briefly, we
evaluated the worth of a subset of features by considering the
individual predictive ability of each feature with respect to the
cleaved/uncleaved class, along with the degree of redundancy
between the features. Using this method, we created a 54–
dimensional projection of the peptide substrates (53 features
plus the class).
Analysis of this lower–dimensional projection revealed that
the features of the outer residues (S4, S4’) are relatively
unimportant, whereas the central residues (S1, S1’) are quite
important in determining cleavability. For the S1 position,
seven parameters were chosen:
• FASG760102: Melting point [26];
• FAUJ880105: Minimum width of the side chain [27];
• PALJ810111: Normalized frequency of beta–sheet in
alpha+beta class [28];
• PRAM900101: Hydrophobicity [29];
• ROBB760107: Information measure for extended without
H-bond [30];
• KOEP990101: Alpha–helix propensity derived from de-
signed sequences [31]; and
• MITS020101: Amphiphilicity index [32].
3) PCA projection of physiochemical properties: Using
the full, 155–dimensional representation of each of the 20
naturally occurring amino acids, we performed principal com-
ponent analysis (PCA) to find linear combinations of features
that capture the variation between different kinds of amino
acids. More formally, PCA, or the Karhunen–Loe`ve transform,
is a linear transformation by which the 20 data points in a
155–dimensional space are projected onto a new coordinate
system. The system is chosen such that the greatest variance
is captured by the first axis, or the first “principal component.”
Successive principal components (axes) capture progressively
less variance. Each component is a linear combination of
some of the initial features; given appropriate uniform nor-
malization, the weight of each feature in a given component
indicates the relative importance of that feature in defining the
component.
Using PCA, we derived 16 principal components that cap-
ture 95% of the variance in the amino acids, with the first
PC capturing 30% of the variance. The set of 746 peptide 8–
mers were projected into a reduced 129–dimensional space:
8 concatenated 16–dimensional residues plus the class of the
peptide.
B. Model creation and classification
For each of the three peptide representations detailed above,
we tested the ability of six machine learning techniques to clas-
sify the peptides as either cleaved or uncleaved. Each of these
models is described below. For each model, we evaluated the
performance using 10x10 cross–validation (see Conclusion):
for each of ten runs, 10% of the peptide dataset was withheld
for testing a classifier trained by the remaining 90% of the
peptides. The sensitivity and specificity of each classifier’s
predictions for all ten of its cross–validation runs can then be
combined to determine the percentage of correctly classified
peptides. This value is used to quantify the classifier’s overall
accuracy and facilitates pairwise comparison of models and
representation schemes.
1) Decision tree model: Decision trees are simple, intuitive
classification schemes that use a series of questions (decisions)
to place a sample in a class with low error rate. More
specifically, a decision tree is a structure in which the internal
branches represent conditions, such as “hydrophobicity index
at S3 > 0.52”. Following these conditions leads to the leaves
of the tree, which are classifications indicating whether the
peptide is cleaved or not. Here, we use a particular variant of
the decision tree, a C4.5 decision tree [33], which is notable
for not being prone to overfitting of input data. An example
decision tree from our experiments is shown in Figure 3.
2) Logistic regression model: A logistic regression is just a
non–linear transformation of a linear regression. In this model,
each independent variable (the different dimensions of our
various projections) are regressed to the class (cleaved or not
cleaved). Here we use a variant of logistic regression that leads
to automated feature selection and is described elsewhere [34].
3) Bayesian network model: Bayesian network models use
directed acyclic graphs to model the joint probability dis-
tribution of each class over all input features. That is, the
CHOP780207_S2’ <= 0.41765
| FAUJ880105_S1 <= 0.57778
| | FASG760102_S1 <= 0.27711: uncleaved (32.0/1.0)
| | FASG760102_S1 > 0.27711
| | | QIAN880122_S4’ <= 0.81022
| | | | PRAM900101_S1 <= 0.27463
| | | | | MEEJ810102_S4 <= 0.33702
| | | | | | RACS820112_S2 <= 0.58621
| | | | | | | ZIMJ680101_S1’ <= 0.52117
| | | | | | | | PRAM820101_S2’ <= 0.43367
| | | | | | | | | ROSM880103_S3’ <= 0.23077: cleaved (2.0)
| | | | | | | | | ROSM880103_S3’ > 0.23077
| | | | | | | | | | CHOP780207_S4 <= 0.21176: cleaved (2.0)
| | | | | | | | | | CHOP780207_S4 > 0.21176: uncleaved (11.0/1.0)
| | | | | | | | PRAM820101_S2’ > 0.43367
| | | | | | | | | RADA880105_S2 <= 0.75274
| | | | | | | | | | PRAM900101_S1 <= 0.06866: cleaved (10.0/2.0)
| | | | | | | | | | PRAM900101_S1 > 0.06866: uncleaved (4.0)
| | | | | | | | | RADA880105_S2 > 0.75274
| | | | | | | | | | QIAN880137_S3’ <= 0.5124: cleaved (69.0/3.0)
| | | | | | | | | | QIAN880137_S3’ > 0.5124
| | | | | | | | | | | RACS820112_S2 <= 0.43103: cleaved (2.0)
| | | | | | | | | | | RACS820112_S2 > 0.43103: uncleaved (4.0/1.0)
| | | | | | | ZIMJ680101_S1’ > 0.52117: cleaved (248.0/7.0)
| | | | | | RACS820112_S2 > 0.58621
| | | | | | | RACS820103_S4 <= 0.43007
| | | | | | | | CHAM830104_S3’ <= 0
| | | | | | | | | RADA880105_S2 <= 0.75274: uncleaved (5.0/1.0)
| | | | | | | | | RADA880105_S2 > 0.75274: cleaved (2.0)
| | | | | | | | CHAM830104_S3’ > 0: cleaved (11.0)
| | | | | | | RACS820103_S4 > 0.43007: uncleaved (6.0)
| | | | | MEEJ810102_S4 > 0.33702
| | | | | | GARJ730101_S4’ <= 0.01426: uncleaved (9.0)
| | | | | | GARJ730101_S4’ > 0.01426
| | | | | | | CHAM830104_S3’ <= 0
| | | | | | | | QIAN880102_S4 <= 0.57143: uncleaved (7.0/1.0)
| | | | | | | | QIAN880102_S4 > 0.57143: cleaved (3.0)
| | | | | | | CHAM830104_S3’ > 0: cleaved (9.0)
| | | | PRAM900101_S1 > 0.27463
| | | | | GEIM800106_S1’ <= 0.94
| | | | | | RACS820102_S3 <= 0.81522
| | | | | | | FAUJ880108_S2’ <= 0.4375: uncleaved (31.0/1.0)
| | | | | | | FAUJ880108_S2’ > 0.4375: cleaved (4.0/1.0)
| | | | | | RACS820102_S3 > 0.81522: cleaved (6.0)
| | | | | GEIM800106_S1’ > 0.94: cleaved (9.0)
| | | QIAN880122_S4’ > 0.81022
| | | | MITS020101_S1 <= 0.35354
| | | | | ZIMJ680101_S1’ <= 0.82085: uncleaved (20.0)
| | | | | ZIMJ680101_S1’ > 0.82085
| | | | | | RACS820102_S3 <= 0.3587: uncleaved (4.0)
| | | | | | RACS820102_S3 > 0.3587: cleaved (5.0)
| | | | MITS020101_S1 > 0.35354: cleaved (2.0)
| FAUJ880105_S1 > 0.57778
| | QIAN880137_S3’ <= 0: cleaved (3.0)
| | QIAN880137_S3’ > 0: uncleaved (37.0/1.0)
CHOP780207_S2’ > 0.41765
| ZIMJ680101_S1’ <= 0.58306: uncleaved (145.0/2.0)
| ZIMJ680101_S1’ > 0.58306
| | PRAM900101_S1 <= 0.27463
| | | FAUJ880105_S1 <= 0.57778
| | | | FAUJ880105_S1 <= 0: uncleaved (2.0)
| | | | FAUJ880105_S1 > 0
| | | | | RACS820103_S3 <= 0.72378
| | | | | | WILM950104_S2 <= 0.44834: uncleaved (5.0)
| | | | | | WILM950104_S2 > 0.44834
| | | | | | | PRAM820101_S2’ <= 0.77041: cleaved (8.0)
| | | | | | | PRAM820101_S2’ > 0.77041: uncleaved (4.0/1.0)
| | | | | RACS820103_S3 > 0.72378: cleaved (9.0)
| | | FAUJ880105_S1 > 0.57778: uncleaved (4.0)
| | PRAM900101_S1 > 0.27463: uncleaved (12.0)
Fig. 3. The decision tree calculated for the CFS, a 54–dimensional
representation of the 8–mer peptides. The branch points are in the form
PARAMETER RESIDUE. For example, CHOP780207 S2’ represents the
AAindex parameter CHOP780207 (normalized frequency of participation in
a C–terminal non–helical region) at the S2’ residue. Values for all AAindex
parameters are normalized to 1 across all amino acids. The tree shows
various questions about a peptide that, when followed, lead to a set of
conclusions. For example, if a given peptide has CHOP780207 S2 <=
0.41765 and FAUJ880105 S1 > 0.57778 and QIAN880137 S3 >
0 then the peptide is classified as uncleaved. As shown in the table, 37 of the
746 known peptides are correctly classified by this scheme and only one is
incorrectly classified.
model captures conditional dependencies between the features
with regards to how they impact the final classification of
each sample. Bayesian networks can be used to find causality
relationships, one of many features that make these models
particularly well–suited to many applications in computational
biology (see, for example, [35]–[37]). The method uses a
Bayesian scoring metric that ranks multiple models based on
their ability to explain data with the simplest possible method.
The Bayesian metric is a function of the probability of the
model being correct given a set of observed data; this is, in
turn, correlated to the model’s prior probability and its phys-
ical likelihood. For a more detailed explanation of Bayesian
networks, see Witten and Frank [25] or Heckerman [38].
4) Naive Bayes model: The naive Bayes model, or “Idiot’s”
Bayes model [39], is a simple machine learning scheme that
assumes naively that each feature has an independent effect
on the classification of each sample [40]. In the case of the
HIV–I protease substrates, this means that the physiochemical
characteristics of the S1 residue contribute to the cleavability
of the peptide in a way that is independent of the other
residues: S1’, S2, etc. The resulting network dependencies
are less complex than one might otherwise obtain from a
Bayesian network model but are frequently useful, particularly
for unwieldy datasets or problems with physical characteristics
that may warrant the assumption of conditional independence
of features.
5) Support vector machine model with linear basis func-
tion: The support vector machine (SVM) is a machine
learning technique posed as a quadratic programming (QP)
problem [41]. The formulation can best be conceptualized by
considering the problem of classifying two linearly separable
groups of points. The first step is to define the “convex hull”
of each group, which is the smallest–area convex polygon that
completely contains a group. The SVM approach looks for
the best linear classifier (single straight line) between the two
groups of points, defined as either the line that bisects the
two closest points on each convex hull or the two parallel
planes tangent to each convex hull that are furthest apart. These
alternative definitions provide two alternative formulations
of a convex QP problem; notably, they both reduce to the
same problem. (A rigorous mathematical treatment of these
qualitative explanations can be found elsewhere [42], [43].)
Tried and true methods for solving QP problems can then
be used to (relatively quickly) determine the best classifier.
This method can be expanded to allow for linearly inseparable
cases by altering the optimization problem to account for a
weighted cost of misclassification when training the model.
There is evidence in the literature that an SVM approach to
defining the best classifier is less susceptible to overfitting and
generalization error [44]–[46].
6) Support vector machine model with radial basis func-
tion: The above description of an SVM, despite accounting
for the possibility of inseparability, does not address the need
for non–linear classifiers. For instance, if the members of one
class fall within a well–defined circle and the non–members
fall outside of the circle, the above method will perform
extremely poorly because it will try to form just one plane
to separate the groups [41]. Rather than attempting to fit
higher–order curves, it is easier to project the input attributes
into a higher–dimensional space in which the groups are
(approximately) linearly separable. The higher–dimensional
spaces can be characteristic of any desired classifier (e.g.,
nonlinear terms generated by multiplying attributes or squaring
attributes). The same method for computing the best linear
classifier is then used. The result is mapped back into attribute
space of the appropriate dimensions and constitutes a non–
linear classifier. Though one may expect such a process
to be prohibitively expensive for data with many attributes,
there exists a computational shortcut using “kernel functions”
to avoid calculating all possible higher–dimensional feature
values. In this work, the basis function for the kernel gives
us the ability to detect optimal classifiers that are based upon
training points’ radius from some center point (as in the above
example).
III. CONCLUSION
Our results show that the full, 1241–dimensional represen-
tation performed the best, followed by the PCA representation
and, finally, the representation made via feature selection. (See
Figure 4 and Table III & IV. In these tables “FULL” is the
full physiochemical, 1241–dimensional representation; “CFS”
is the feature–selected, 55–dimensional representation; and
“PCA” is the 129–dimensional representation created using
principal component analysis.)
Fig. 4. Classification results for all amino acid representations and model
types. The three different amino acid representations are shown in shades of
gray: “FULL” is the full physiochemical, 1241–dimensional representation;
“CFS” is the feature–selected, 55–dimensional representation; and “PCA” is
the 129–dimensional representation using created using princple component
analysis (see text). Error bars show the standard deviation over the 10x10
cross–validation test (100 samples per representation/model combination with
a total of 1800 tests.) The best performing model was the SVM with
radial basis function (SVM–rbf in the figure) with the full 1241–dimensional
feature vector representing each eight–residue sequence. Averaged over all
representations, the logistic regression model is best (see Table I). The poorest
performing model is the decision tree (DT) with the 129–dimensional feature
vector created using the PCA projections created as described in the text. In
general the full 1241–dimensional representation performed the best, followed
by the PCA representation and finally the CFS representation, which was
created by a feature selection process.
Of the models tested, results show that logistic regression
is the best, followed by (linear basis function) SVMs and
Bayesian networks (See Figure 4 and Table I & II.) The
single best model/representation combination was the SVM
model with radial basis function (SVM–rbf) and the FULL
representation. It is worth noting that though this single
combination was the best, the radial basis function SVM itself
did not perform consistently well. Though this may not have
been expected, it is definitely reasonable per the “No Free
TABLE I
MODEL COMPARISON
DT LR NB BN SVM SVM–rbf
DT - 2 1 3 2 2
LR 0 - 0 0 0 0
NB 0 3 - 1 2 1
BN 0 1 0 - 1 1
SVM 0 0 0 0 - 1
SVM–rbf 0 2 0 1 2 -
Each i, j entry represents the number of representations, out of
three, for which the i model performed worse than the j model.
Here “worse” means that the model had a statistically significant
lower performance, based on a two–tailed t–test at the 0.05
confidence level.
TABLE II
MODEL RANKING
total wins total losses model
8 0 LR
7 1 SVM
5 3 BN
5 5 SVM–rbf
1 7 NB
0 10 DT
Each row shows, for each model, how many other
model/representation pairs that model (with any representation)
“wins” against. (Thus, the max of the sum of the columns in any
row is 18− 3 = 15; however, ties are not shown.) Here “win/loss”
means that the model had a statistically significant higher/lower
performance, based on a two–tailed t–test at the 0.05 confidence
level.
Lunch” theorem: no single machine–learning method should
be expected to perform the best in all cases [47].
In general, these results suggest that higher–dimensional
physiochemical representations tend to have better perfor-
mance than representations incorporating fewer dimensions
selected on the basis of high information content. As such, it
seems that as long as the training set is a reasonable size, more
accurate classifiers can be constructed by keeping as many
significant input attributes as possible. Though methods like
principal components analysis help to reduce computational
complexity for unwieldy datasets, it is better to avoid feature
selection until a supervised method (like the models tested in
this work) can determine which features are most important
in classifying samples.
TABLE III
REPRESENTATION COMPARISON
FULL CFS PCA
FULL - 0 1
CFS 3 - 4
PCA 2 1 -
Each i, j entry represents the number of models, out of six, for
which the i representation performed worse than the j
representation. Here “worse” means that the representation had a
statistically significant lower performance, based on a two–tailed
t–test at the 0.05 confidence level.
TABLE IV
REPRESENTATION RANKING
5 1 FULL
5 3 PCA
1 7 CFS
Each row shows, for each representation, how many other
model/representation pairs that representation (with any model)
“wins” against. (Thus, the max of the sum of the columns in any
row is 18− 6 = 12; however, ties are not shown.) Here “win/loss”
means that the representation had a statistically significant
higher/lower performance, based on a two–tailed t–test at the 0.05
confidence level.
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